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Summary
Two strategies involving whole-genome association
studies have been proposed for the identification of genes
involved in complex diseases. The first one seeks to char-
acterize all common variants of human genes and to test
their association with disease. The second one seeks to
develop dense maps of single-nucleotide polymorphisms
(SNPs) and to detect susceptibility genes through linkage
disequilibrium. We performed a molecular screening of
the coding and/or flanking regions of 36 candidate genes
for cardiovascular diseases. All polymorphisms identi-
fied by this screening were further genotyped in 750
subjects of European descent. In the whole set of genes,
the lengths explored spanned 53.8 kb in the 5′ regions,
68.4 kb in exonic regions, and 13 kb in the 3′ regions.
The strength of linkage disequilibrium within candidate
regions suggests that genomewide maps of SNPs might
be efficient ways to identify new disease-susceptibility
genes, provided that the maps are sufficiently dense.
However, the relatively large number of polymorphisms
within coding and regulatory regions of candidate genes
raises the possibility that several of them might be func-
tional and that the pattern of genotype-phenotype as-
sociation might be more complex than initially envis-
aged, as actually has been observed in some
well-characterized genes. These results argue in favor of
both genomewide association studies and detailed stud-
ies of the overall sequence variation of candidate genes,
as complementary approaches.
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Introduction
In recent years, there has been considerable effort to
understand the contribution of genetic factors to human
disease. Although success has been undeniable in the
discovery of genes underlying Mendelian disorders, the
identification of genes involved in common diseases ap-
pears to be far more complicated than initially antici-
pated (Collins et al. 1997). It has been progressively
realized that linkage studies, the strategy successfully ap-
plied to Mendelian disorders, has low power to detect
genes with modest effects, such as those involved in com-
plex diseases, and it is now often proposed that asso-
ciation studies might be more efficient for identification
of susceptibility genes underlying common disorders
(Lander 1996; Risch and Merikangas 1996; Cambien et
al. 1997; Collins et al. 1997).
A current limitation of association studies is that they
are restricted to already known candidate genes. Major
recent developments, however, have led to the consid-
eration of whole-genome association studies. Two dif-
ferent strategies have been proposed (Collins et al.
1997). The first one is linked to the completion of the
Human Genome Project, aimed at producing the com-
plete nucleotide sequence of the ∼100,000 human genes.
One of the goals proposed for the postgenome phase is
the systematic identification of all common variants in
human genes (Lander 1996). By cataloging all common
variants, it would be possible to test directly the asso-
ciation of each of them with disease.
The second strategy involves the use of very dense
maps of single-nucleotide polymorphisms (SNPs) evenly
distributed over the whole genome so that every gene
would be covered or narrowly flanked by one or a few
SNPs, allowing indirect detection of its effects through
linkage disequilibrium between SNPs and a functional
variant of the gene (Risch andMerikangas 1996; Collins
et al. 1997).
There is limited information about the natural se-
quence diversity in human genes that could help to iden-
tify the most efficient strategy. The choice of a strategy
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is dependent on a number of critical elements, including
the number of functional polymorphisms within a gene,
the combination of their effects, their allele frequencies,
and the extent of linkage disequilibrium among them.
Examples of some well-characterized genes—such as the
angiotensin I–converting enzyme (ACE) (Villard et al.
1996), apolipoprotein (apo) E (Davignon et al. 1988;
Lambert et al. 1998), or cholesteryl ester transfer protein
(CETP) (authors’ unpublished data) genes—indicate
that the presence of several functional polymorphisms
within a gene is likely and that the pattern of genotype-
phenotype association can be quite complex, owing, in
particular, to considerable linkage disequilibrium be-
tween polymorphisms.
We have recently undertaken a program of explora-
tion of candidate genes for cardiovascular diseases, and,
as a first step of this ongoing program we have per-
formed an extensive molecular screening of the coding
and/or flanking regions of 36 genes. All polymorphisms
identified by this screening were further genotyped in
750 European population-based control subjects of the
ECTIM (Etude Cas-Te´moin sur l’Infarctus du My-
ocarde) study (Parra et al. 1992). The statistics derived
from the study of these 36 genes provide new insights
into the type and amount of DNA-sequence variation
that might be expected in human genes.
Material and Methods
The ECTIM Population-Based Samples
The ECTIM study (Parra et al. 1992) is a case-control
study of myocardial infarction conducted in four regions
covered by WHO MONICA (monitoring in cardiovas-
cular disease) registers: Belfast (Northern Ireland), Lille
(northern France), Strasbourg (eastern France), and Tou-
louse (southern France). In each region, a population-
based control group was composed of men of age 25–64
years (mean age 53.3  8.5 years) randomly sampled
from the population covered by the register. To increase
ethnic homogeneity, the subjects had to be residents of
the region where they were recruited, their parents had
to have been born in this same region, and their four
grandparents had to have been born in Europe. Informed
consent was obtained from all participants.
Screening of the Genes and Genotyping of
Polymorphisms
Genomic DNA was prepared from white blood cells
by phenol extraction. The molecular screening of the
genes was performed by comparing 40 chromosomes
from 20 unrelated patients, each of whom had suffered
a myocardial infarction. DNA-sequence variations were
identified by PCR/SSCP (Orita et al. 1989). From the
known (published or identified) sequences of genes,
overlapping fragments were amplified enzymatically to
cover the entire coding sequence and the flanking
regions. The mean size of PCR fragments used for the
initial SSCP was 254 bp (SE 67; range 87–478). Most
(95%) of the fragments were !350 bp in size.
Each amplification was performed by use of 250 ng
of DNA in a total volume of 50 ml, containing 10 mmol
Tris-HCl (pH 9)/liter, 50 mmol KCl/liter, 1.5 mmol
MgCl2/liter 0.1% Triton X-100, 0.2 mg BSA/ml, 200
mmol each dNTPs/liter, 25 pmol of each amplimer/liter,
and 0.2 U Taq polymerase. For the SSCP analysis, 0.12
mCi of a[-32P]-dCTP were added to the 50-ml mix. Am-
plification products were then diluted twofold in a so-
lution containing 95% formamide, 10 mmol EDTA/liter,
0.05% bromophenol blue, and 0.05% xylene cyanol.
After denaturation at 95C for 5 min, the samples were
placed on ice, and 4 ml were loaded onto nondenaturing
8% acrylamide gels (acrylamide:bisacrylamide ratio 39:
1). Electrophoresis was performed, at room temperature,
with a cooling fan and 40 W constant power for 6 h on
gels containing 0% and 7.5% glycerol. Thereafter the
gels were dried and autoradiographed overnight at
80C, with an intensifying screen.
DNA from subjects presenting a different SSCP pat-
tern of migration was reamplified by PCR with unla-
beled primers. PCR products were then purified and se-
quenced by the Sanger method (Sanger et al. 1997) in
25 cycles of PCR with g[-32P]-dATP end-labeled primer,
by a direct sequencing kit (AmpliCycle; Perkin-Elmer,
Roche Molecular Systems). The method of detection by
PCR/SSCP is not 100% sensitive but 190% of already
known polymorphisms were actually detected, which
provides an estimate of the sensitivity of the technique
used.
Polymorphisms were then genotyped in the 750 pop-
ulation-based controls of the ECTIM study, by allele-
specific oligonucleotides (ASOs) (Saiki 1986). After en-
zymatic amplification of the fragment encompassing the
polymorphism, 1/5 of the PCR product was denatured
in 150 ml of 0.5M NaOH and 1.5 M NaCl with 10 ml
of 0.05% bromophenol blue solution and was blotted
onto nylon membranes (Hybond N; Amersham). Each
allele was detected after preincubation of the mem-
branes, for 2 h with 100 pmol of unlabeled oligonu-
cleotide probe specific for the other allele, followed by
incubation for 2 h with 20 pmol of the labelled probe
specific for the allele. The melting temperature (Tm ) used
for hybridization was calculated by adding 4C for each
C or G and 2C for each A or T and then subtracting
5C from the total. The membranes were washed twice
at room temperature in 1 # SSC for 5 min, followed
by 5 min in 0.5 # SSC at Tm  3C.
All information needed for genotyping polymor-
phisms (PCR primers, probes, and temperatures) can be
obtained at our Internet site, Canvas (see Electronic-
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Figure 1 Plot of number of detected polymorphisms versus
length of scanned regions. Blackened circles denote genes in which 5′,
exonic, and 3′ regions were scanned ( ); triangles denote genesn  21
in which 5′ and exonic regions were scanned ( ); unblackenedn  11
circles denote genes in which only the 5′ region was scanned ( ).n  4
Database Information), except for the MSR1 gene, for
which the gene sequence was confidentially communi-
cated to us. The gene abbreviations used in this paper
are taken from OMIM (see Electronic-Database In-
formation).
Statistical Analysis
All population-related statistics were estimated in the
750 population-based controls from the ECTIM study.
Since, for the vast majority of polymorphisms, allele fre-
quencies and pairwise linkage-disequilibrium coeffi-
cients did not statistically differ between populations,
subjects from the four populations were pooled for anal-
ysis. The statistics computed were (i) the lengths of the
regions explored in each gene; (ii) the number of poly-
morphic sites found; (iii) the population allele frequen-
cies of polymorphisms; (iv) the heterozygosity (h) esti-
mated at each single varying site; (v) the nucleotide
diversity (p), defined as the expected number of differ-
ences, per nucleotide site, between a random pair of
chromosomes drawn from the population, a number
that is equivalent to heterozygosity at the nucleotide
level, averaged across all nucleotide sites, includingmon-
omorphic sites; (vi) the overall heterozygosity (H)
yielded by the whole set of polymorphisms identified in
a gene, which is the proportion of heterozygotes per gene
locus when all polymorphisms across the gene are com-
bined into haplotypes, as computed from haplotype fre-
quencies estimated by the MYRIAD program (MacLean
and Morton 1985); and (vii) the pairwise linkage-dise-
quilibrium coefficients (D′) between diallelic polymor-
phisms, estimated by log-linear model analysis (Tiret et
al. 1991). The extent of disequilibrium was expressed
as the ratio of the unstandardized coefficient to its max-
imal/minimal value. For each gene, the mean linkage
disequilibrium was calculated by averaging the k(k1)/
2 pairwise disequilibrium coefficients (k no. of diallelic
polymorphisms within a gene). An association between
two diallelic polymorphisms was considered as complete
or nearly complete if !10% of subjects were off the
diagonal of the 3#3 contingency table of genotypes ob-
served in the 750 controls.
Results
Sequence Diversity in the 36 Genes
The investigated genes were selected for their possible
involvement in common cardiovascular disorders such
as coronary heart disease or hypertension. They code for
growth factors, for cytokines, for neuromediators, and
for molecules involved in lipid metabolism, calcium me-
tabolism, vascular and cardiac trophicity, thrombosis,
and adhesion (table 1). The screening of the genes was
performed by comparing 40 chromosomes from 20 un-
related patients with myocardial infarction.
The gene sequences were divided into three regions:
5′ flanking (upstream from the transcription start), ex-
onic (including untranslated exons), and 3′ flanking. In
the whole set of genes, the total lengths explored
spanned 53.8 kb in the 5′ flanking regions, 68.4 kb in
the exonic regions, and 13 kb in the 3′ flanking regions.
The mean length explored in a gene was 3.8 kb, with a
large range of variation: from 750 bp in the FGG gene
to nearly 20 kb in the APOB gene. In 4 of the 36 genes
(LPA, FGA, FGG, and VDR), only the 5′ region was
explored in a systematic way.
The total number of identified polymorphic sites was
164 (mean 4.6 [range 0–24]). The largest number of
polymorphisms ( ) was in the APOB gene (Poiriern  24
et al. 1996). In 5 of the 36 genes (FGA, ADRB1, CSF1,
ECE, and HGF), no polymorphic site was found in the
regions explored (table 1). As expected, the number of
polymorphisms in a gene was positively correlated with
the length of the scanned sequences (Spearman corre-
lation coefficient ; ) (fig. 1).[r]  0.48 P  .003
Allele frequencies of the polymorphisms were esti-
mated in 750 subjects from the ECTIM study. Sixteen
of the polymorphisms were rare variants (frequency
!.01), and 10 were multiallelic polymorphisms, the re-
mainder being common diallelic polymorphisms (SNPs
or insertion/deletion variations). For polymorphisms
whose minor-allele frequency was in the range .01–.10,
the observed number was corrected for their probability
of detection, by comparison of 40 chromosomes. Poly-
morphisms with a higher allele frequency had a prob-
ability of almost 1 of being detected by this approach.
For rare variants (frequency !.01), no attempt to correct
their number was made, because accurate correction
Table 1
Lengths Explored and Number of Polymorphisms Found in 36 Genes
GENE ABBREVIATION CHROMOSOME
LENGTH EXPLORED [NO. OF POLYMORPHISMS FOUND]a
5′ Regions Exonic Regions 3′ Regions Total
a2A Adrenergic receptor ADRA2A 10q 2,041 [3] 1,350 [1] 173 [0] 3,564 [4]
Aldosterone synthase CYP11B2 8q 660 [2] 2,097 [4] 0 [)] 2,757 [6]
Angiotensin-II type 1 receptor AGTR1 3q 2,558 [8] 2,606 [6] 836 [0] 6,000 [14]
Apolipoprotein (a) LPA 6q 1,441 [4] 0 [)] 0 [)] 1,441 [4]
Apolipoprotein B APOB 2p 3,656 [4] 15,803 [19] 300 [1] 19,759 [24]
b1 adrenergic receptor ADRB1 10q 3,097 [0] 1,444 [0] 93 [0] 4,634 [0]
Cholesteryl ester transfer protein CETP 16q 805 [2] 1,590 [3] 911 [2] 3,306 [7]
Colony stimulating factor 1 CSF1 5q 748 [0] 225 [0] 34 [0] 1,007 [0]
Early growth response protein 1 EGR1 5q 918 [1] 1,632 [0] 1,228 [1] 3,778 [2]
Endothelin 1 EDN1 6p 2,955 [3] 639 [2] 48 [0] 3,642 [5]
Endothelin converting enzyme ECE 1p 219 [0] 3,600 [0] 0 [)] 3,819 [0]
Endothelin-A receptor EDNRA 4 858 [0] 4,122 [5] 38 [1] 5,018 [6]
Endothelin-B receptor EDNRB 13q 1,001 [1] 4,307 [2] 36 [0] 5,344 [3]
Fibrinogen a FGA 4q 800 [0] 0 [)] 0 [)] 800 [0]
Fibrinogen b FGB 4q 1,500 [5] 1,395 [2] 2,500 [1] 5,395 [8]
Fibrinogen g FGG 4q 750 [1] 0 [)] 0 [)] 750 [1]
Granulocyte-macrophage colony–stimulating factor CSF2 5q 663 [0] 435 [1] 503 [0] 1,601 [1]
Hepatocyte growth factor HGF 7q 86 [0] 2,190 [0] 75 [0] 2,351 [0]
Insulin-like growth factor-1 IGF1 12q 1,630 [2] 927 [1] 648 [0] 3,205 [3]
Intercellular circulating adhesion molecule-1 ICAM1 19p 1,392 [1] 1,599 [4] 0 [)] 2,991 [5]
Interleukin 1-a IL1A 2q 1,437 [1] 2,021 [2] 0 [)] 3,458 [3]
Interleukin 6 IL6 7p 1,158 [3] 609 [0] 237 [1] 2,004 [4]
Macrophage-scavenger receptor MSR1 8p 2,345 [2] 117 [0] 0 [)] 2,462 [2]
Matrix Gla protein MGP 12p 3,200 [6] 311 [2] 269 [0] 3,780 [8]
Microsomal triglyceride transfer protein MTP 4q 732 [2] 52 [0] 0 [)] 784 [2]
NO synthase endothelial NOS3 7q 1,021 [3] 1,614 [3] 0 [)] 2635 [6]
NO synthase inducible NOS2A 17q 1,090 [3] 191 [0] 10 [0] 1,291 [3]
P-selectin SELP 1q 4,866 [5] 3,152 [8] 0 [)] 8,018 [13]
Platelet-derived growth factor A PDGFA 7p 1,787 [0] 645 [1] 2,305 [4] 4,737 [5]
Platelet-derived growth factor A-receptor A PDGFRA 4q 2,122 [6] 160 [1] 0 [)] 2,282 [7]
Scavenger receptor CD36 7q 273 [0] 2,641 [1] 25 [0] 2,939 [1]
Thrombin receptor TR 5q 225 [1] 1,278 [0] 1,970 [2] 3,473 [3]
Transforming growth factor b1 TGFB1 19q 1,138 [3] 2,533 [4] 0 [)] 3,671 [7]
Tumor necrosis factor a TNF 6p 1,053 [5] 4,066 [0] 0 [)] 5,119 [5]
Vascular-cell adhesion molecule-1 VCAM1 1p 2,355 [1] 3,064 [0] 766 [0] 6,185 [1]
Vitamin D receptor VDR 12q 1,228 [1] 0 [)] 0 [)] 1,228 [1]
Total 53,808 [79] 68,415 [72] 13,005 [13] 135,228 [164]
a An ellipsis ()) indicates that the no. of polymorphisms was not determined.
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Figure 2 Distribution of polymorphisms according to allele fre-
quency estimated in 750 subjects. The light gray shading indicates the
frequency corrected for the probability of detection by using 40 chro-
mosomes. Rare variants (frequency !.01) are not represented because
of the lack of precision of correction.
would be impossible. As a consequence, these variants
were not included in the estimation of sequence diversity.
These variants, although of interest from a population-
history aspect, are unlikely to contribute substantially
to the genetic components of common diseases (Cam-
bien et al. 1997).
After correction for the probability of detection, the
expected number of polymorphisms, excluding rare var-
iants, was 164 ( in 5′ regions, in exonicn  79 n  71
regions and in 3′ regions), coincidentally equal-n  14
ing the total number of observed polymorphisms. The
number of polymorphisms decreased as their allele fre-
quency increased in the population (fig. 2). Nearly one-
third of polymorphisms had a frequency !0.1.
The mean  SE h estimated across all polymorphic
sites (when rare variants were excluded) was .301 
.014. The mean SE p estimated from the pooled genes
was .00037 .00005, which means that two randomly
chosen sequences from the population are expected to
differ approximately every 2,700 bp. The mean  SE
p was 0.00044  0.00008 in the 5′ and 3′ regions (1
variable site/2,300 bp) and .00030 .00007 in the ex-
onic regions (1 variable site/3,400 bp). The lower se-
quence diversity observed in exonic regions versus flank-
ing regions of the 36 genes presumably reflects a more
stringent selective pressure in coding versus noncoding
sequences.
Type of Polymorphism
In accordance with previous observations (Li and Sad-
ler 1991; Kwok et al. 1996; Nickerson et al. 1998), the
vast majority of varying sites (85%) were single-base
substitutions. Although transversions are theoretically
twice as frequent as transitions, transitional changes ac-
tually occurred more often than transversional changes,
as already reported (Vogel and Kopun 1977; Li et al.
1984; Collins and Jukes 1994). In the 36 genes, the
transition rate exceeded the transversion rate by a ratio
of 2.3:1. The relative number of transitions/transver-
sions and the type of substitution were not significantly
different among regions of the genes. The frequencies of
the different substitutions were A/G (39.3%), C/T
(30.0%), G/C (12.9%), G/T (7.9%), A/C (7.1%), and
A/T (2.9%). The higher prevalence of A/G substitutions
is in accordance with previous observations in functional
genes (Gojobori et al. 1982). Among the 164 polymor-
phisms identified, 13 (7.9%) were insertion/deletion var-
iations and 10 (6.1%) were repeat polymorphisms. All
insertion/deletion variations (with one exception, which
affected the coding sequence of the signal peptide of the
APOB gene) and all repeat polymorphisms were found
in untranslated sequences (5′ and 3′ flanking regions or
untranslated exons).
Seventy-two polymorphic sites were identified in ex-
onic regions, among which 12 (17%) occurred in un-
translated sequences. Among the 60 remaining poly-
morphisms, 40 (67%) were nonsynonymous (i.e. they
led to an amino acid change). The proportion of non-
synonymous mutations was not significantly different
from the 71% proportion expected by chance if all co-
dons were assumed to be equally frequent in the genome
and if the probability of substitution was the same for
all pairs of substitutions (Nei 1987). All substitutions
occurring at the first nucleotide position ( ) weren  18
nonsynonymous, as compared with a proportion of 95%
expected under random substitution. At the second nu-
cleotide position, all substitutions were nonsynonymous
by definition. At the third nucleotide position, 20 (87%)
of the 23 substitutions were synonymous, a proportion
not significantly different from the 72% expected by
chance. This result suggests, at most, only a weak se-
lective pressure acting on common polymorphisms af-
fecting coding regions of candidate genes for complex
diseases. This might be because, unlike rare genetic de-
fects involved in monogenic diseases, common poly-
morphisms that influence human health and disease sus-
ceptibility have no dramatically deleterious effect.
Moreover, in most cases their detrimental effect would
appear relatively late in life.
Linkage Disequilibrium and H
The mean pairwise linkage disequilibrium could be
estimated in 22 of the 36 genes. Among the 14 remaining
genes, 5 were not polymorphic (FGA, ADRB1, CSF1,
ECE, and HGF), 5 had only one polymorphism (CD36,
FGG, CSF2, VCAM1, and VDR), and in the remaining
4 genes (IGF1, NOS2A, MSR1, and PDGFA), the poly-
morphisms involved were too rare (!.01) or multial-
lelic (repeat polymorphisms). In the 22 genes, the mean
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Figure 3 Mean D′ between diallelic polymorphisms and overall
heterozygosity (H), conveyed by the whole set of polymorphisms
within a gene, estimated in 750 subjects.
 SE pairwise disequilibrium was .86 .03 (fig. 3). In
18 of the 22 genes, the mean linkage disequilibrium was
10.80, reflecting a strong nonrandom association among
polymorphisms within candidate regions. There were,
however, a few exceptions, in which polymorphisms
within a gene exhibited little association. As an example,
in the AGTR1 gene, a group of polymorphisms located
in the 5′ flanking region was in weak linkage disequilib-
rium with a group of polymorphisms located in the ex-
onic and 3′ flanking regions, probably because the two
groups are separated by one large intron (Poirier et al.
1998).
The mean  SE of H conveyed by the whole set of
polymorphisms within a gene was .48  .05, and
reached .57  .04 after exclusion of the nonpoly-
morphic genes. There was a strong negative correlation
between the mean pairwise linkage disequilibrium and
H ( , ) (fig. 3). This correlation reflectsr  .72 P ! .001
that the stronger the nonrandom association between
polymorphisms, the lower the information added by
each polymorphism to the set of the others. The high H
observed in several genes (10.7 in 10 of the 36 genes)
has potential implications for linkage studies, since it
may be more efficient to combine several highly infor-
mative SNPs within a candidate region than to use a
microsatellite.
Complete or Nearly Complete Association Between
Polymorphisms
Complete or nearly complete association between
polymorphisms was frequently observed (i.e., genotypes
at different sites were almost completely concordant and
generated only two main haplotypes). Such a pattern of
nearly complete association could extend over several
polymorphic sites within a gene. For example, in the
APOB gene (Poirier et al. 1996), we observed three pairs
of polymorphisms in nearly complete association, aswell
as one triplet (fig. 4). An extreme example was found
in the FGB gene, where six polymorphisms were in
nearly complete association at both ends of the gene and
generated two main haplotypes (Behague et al. 1996).
In the total of 36 genes, we observed 10 combinations
of two polymorphisms (in the APOB, CETP, EDN1,
EDNRA, IL1A, IL6, and TGFB1 genes), 3 combinations
of three polymorphisms (in the APOB, NOS3, and SELP
genes), 1 combination of four polymorphisms (in the
CYP11B2 gene), and 3 combinations of six polymor-
phisms (in the AGTR1, FGB, and PDGFRA genes) in
nearly complete association. Such associations among
polymorphisms over long distances suggest the existence
of ancestral haplotypes and raise important questions
about both the population-historic processes that gen-
erated these haplotypes and the potential functionality
of the haplotypes.
Discussion
The present study, based on a systematic screening of
36 candidate genes for cardiovascular diseases, provides
an estimate of sequence diversity in human genes from
European populations. Because rare variants were not
included in the calculation of nucleotide diversity, the
figures reported here represent a lower bound of the
actual DNA-sequence diversity in the explored genes.
However, it should be noted that the contribution of
rare variants to nucleotide diversity is rather small. For
example, 9 variants, each with a frequency of .01, would
have roughly the same contribution as one single poly-
morphismwith an allele frequency of .10. The nucleotide
diversity estimated from the present data was of the same
order of magnitude as that obtained from an analysis
comparing published human DNA sequence data from
49 different loci (Li and Sadler 1991). By contrast, a
much higher nucleotide diversity (.002) was recently re-
ported across a region of the lipoprotein lipase gene, in
a study comparing sequence data from 71 individuals
from three populations (Nickerson et al. 1998). The nu-
cleotide diversity was very similar in the three popula-
tions, despite their different demographic histories (Af-
rican Americans, Europeans, and European Americans).
Several reasons might explain the difference observed
for the nucleotide diversity estimated in the present
study. First, 90% of the sequence screened in the lipo-
protein lipase gene was located in introns, in which, as
expected, the sequence diversity was found to be four-
fold higher than that in coding regions. Second, most of
the varying sites in the lipoprotein lipase gene were rare
variants found in one or two individuals, whereas, in
our estimation of nucleotide diversity, we did not include
such variants. Third, our study of 36 genes indicates
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Figure 4 Examples of nearly complete associations between groups of polymorphisms in APOB gene. The codon affected is identified by
a “C” prefix to the codon number. Exons are shown as gray boxes, and their numerical designations are in italics (some exons are skipped,
and the drawing is not to scale). The numbering of the variants in the 5′ flanking region is from the transcription start site. Polymorphisms
enclosed in boxes are in almost complete association.
that there is a variability, in the sequence diversity,
among genes. For example, when we selected the 10
genes in which the scanned sequences were 14 kb (in
order to have more reliable estimates), the nucleotide
diversity varied from 0 (ADRB1 gene) to .006 (PDGFA
gene).
This systematic survey of the sequence variation of a
set of candidate genes for cardiovascular diseases pro-
vides a number of elements that might be relevant to the
strategy of association studies. First, they demonstrate
the presence of a relatively large number of common
polymorphisms within coding and regulatory regions of
candidate genes. This raises the possibility that several
of these polymorphisms might be functional. Second,
they reveal a strong pattern of nonrandom association
among polymorphic sites within genes, complete linkage
disequilibrium between two polymorphisms being a
common feature. Third, nearly complete association
among several polymorphisms within a gene is fre-
quently present. Apart from the redundancy of infor-
mation yielded by completely concordant polymor-
phisms, this observation raises the possibility of
functional haplotypic combinations.
The strong linkage disequilibrium observed within
candidate regions suggests that genomewide maps of
SNPs might be efficient tools for identification of new
genes involved in complex diseases. Indeed, one can ex-
pect from the results of the present study that an anon-
ymous SNP, if it occurs within a gene or in its immediate
vicinity, has a high probability of being in linkage dis-
equilibriumwith functional mutations of the gene. How-
ever, genomewide association studies imply that maps
of SNPs should be sufficiently dense, since linkage dis-
equilibrium rapidly decreases with distance across the
genome. This strategy might be more efficient in genet-
ically isolated populations, in which linkage disequilib-
rium extends over larger distances. Moreover, it is im-
portant to realize that this strategy does not allow the
exclusion of regions of the genome, since a given SNP
could be in linkage disequilibrium with several func-
tional mutations that have opposite effects on the phe-
notype, which might obscure association.
If a whole-genome association study may be suitable
for identification of new disease-susceptibility genes, un-
derstanding the underlying biological mechanisms re-
quires a gene-specific approach and a study of the overall
sequence variation of candidate genes. Indeed, the pat-
tern of genotype-phenotype association might be far
more complex than envisaged in early association studies
that assumed a single functional variant within a gene.
There are several examples in which this assumption
proved to be too simplistic. One such example is that
of the ACE gene, in which an insertion/deletion poly-
morphism in intron 16 was shown to be strongly as-
sociated with plasma ACE levels (Tiret et al. 1992). An
extensive molecular screening of the regulatory and cod-
ing sequences of the ACE gene further revealed that there
were probably two functional polymorphisms in strong
linkage disequilibrium with each other, acting additively
on ACE levels (Villard et al. 1996). Another example is
provided by the CETP gene, in which a TaqI polymor-
phism was shown to be associated with both CETPmass
and HDL-cholesterol, in interaction with alcohol con-
sumption (Fumeron et al. 1995). A systematic molecular
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screening of the CETP gene further suggested that there
were at least three functional polymorphisms influencing
CETP mass and HDL-cholesterol levels, through distinct
mechanisms (authors’ unpublished data). As a final ex-
ample, we may consider the well-known APOE poly-
morphism, which is characterized by the presence of
three common alleles generated by two polymorphisms
affecting codons 112 and 158 (Davignon et al. 1988).
A third polymorphism, located in the promoter of the
gene and in linkage disequilibrium with the two others,
has recently been shown to affect apoE expression (Lam-
bert et al. 1998). These examples suggest that the overall
polymorphism of a gene should be investigated, not just
a few markers. They also highlight the importance of
measuring relevant intermediate phenotypes, as a way
to progress toward the identification of functional poly-
morphisms, which is the ultimate goal of genetic studies.
If it is assumed that the mean number of common
polymorphisms within regulatory and coding sequences
is ∼4/gene, then 400,000 polymorphisms would have to
be identified to characterize the entire variability of hu-
man genes. Such identification may soon be within the
scope of the new technologies developed for investiga-
tion of DNA-sequence variation. One of the major goals
of the postgenome phase (Lander 1996) will be to char-
acterize this variability. Whether intronic sequences will
have to be investigated integrally or only partly is an
open question. As part of our work on 36 genes, a num-
ber of polymorphisms were identified in the regions of
introns flanking the exons (data not reported). Obvi-
ously, some of these polymorphisms may have a func-
tional impact.
Our own objective is to focus on the variability of
candidate genes for cardiovascular disorders and to in-
vestigate the role of the detected polymorphisms in a
number of association studies (see our Internet site, Can-
vas, for a list of available studies). For the genes already
explored, our Internet site provides a detailed description
of polymorphisms, allele frequencies, pairwise linkage-
disequilibrium coefficients, haplotype frequencies, and
conditions of PCR/SSCP and genotyping.
In conclusion, the present study on 36 candidate genes
argues in favor of both genomewide association studies
and detailed studies of the overall sequence variation of
candidate genes, as complementary approaches. For the
gene-specific approach, the availability of intermediate
phenotypes and clinical endpoints relevant from a ge-
netic perspective will be a crucial requirement. Pheno-
type, rather than genotype, may rapidly become the ma-
jor challenge of genetic research of complex diseases.
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